This opportunity is no longer accepting applications.
grant admin_console 963155
Accelerating Drug Discovery for Frontotemporal Degeneration
There are currently no FDA approved disease-modifying treatments available for frontotemporal dementia (FTD), and symptomatic treatments only provide limited benefit for patients. Recent scientific advances have provided an increased understanding of pathogenic mechanisms underlying FTD and are …
Funding Source
Agency: Alzheimer's Drug Discovery Foundation
Awards & funding
Total Funding: $300,000
Award Ceiling: $300,000
Award Floor: $300,000
Eligibility
Funding is open to researchers and clinicians in the U.S. and worldwide working in:
- Academic medical centers and universities or nonprofits. Industry partnerships are encouraged.
- Biotechnology companies that demonstrate a clear need for nonprofit funding. Existing companies…
Dates
Application Deadline: May 11, 2026
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers